Haemophilus influenza type a (Hia): Difference between revisions
From Guide to YKHC Medical Practices
No edit summary |
|||
| Line 1: | Line 1: | ||
'''Pathophysiology:''' | '''Pathophysiology:''' | ||
'''Epidemiology:''' | |||
<br/>'''Demographics:''' | <br/>'''Demographics:''' | ||
<br/>'''Signs/Symptoms:''' | <br/>'''Signs/Symptoms:''' | ||
<br/>'''Diagnosis:''' | <br/>'''Diagnosis:''' | ||
<br/>'''Management:''' | <br/>'''Management:''' | ||
<br/>'''Critical Times for Affected Patients:''' | <br/>'''Critical Times for Affected Patients:''' | ||
===Resources/References=== | ===Resources/References=== | ||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692295/| Invasive disease due to ''Haemophilus influenza'' type A in children in Canada’s north: A priority for prevention] | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692295/| Invasive disease due to ''Haemophilus influenza'' type A in children in Canada’s north: A priority for prevention] | ||
Revision as of 12:35, 22 November 2020
Pathophysiology:
Epidemiology:
Demographics:
Signs/Symptoms:
Diagnosis:
Management:
Critical Times for Affected Patients:
Resources/References
- Invasive disease due to Haemophilus influenza type A in children in Canada’s north: A priority for prevention
- Plumb et al. Invasive Haemophilus influenzae Serotype a Infection in Children: Clinical Description of an Emerging Pathogen — Alaska, 2002–2014. Pediatr Infect Dis J. 2018 April ; 37(4): 298–303. doi:10.1097/INF.0000000000001764
